Meta-Analysis of Novel Glucose-Lowering Agents in Patients With Type 2 Diabetes Mellitus Without Pre-existing Heart Failure

Am J Cardiol. 2022 Jul 1:174:184-188. doi: 10.1016/j.amjcard.2022.04.001. Epub 2022 May 2.

Authors

Aymen Ahmed¹, Izza Shahid², Ahmed Kamal Siddiqi², Aayat Ellahi³, Qazi Shurjeel¹, Ahmed Mustafa Rashid³, Talha Maniya²

Affiliations

¹ Department of Medicine, DOW University of Health Sciences, Karachi, Pakistan.
² Department of Medicine, Ziauddin Medical University, Karachi, Pakistan.
³ Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.

PMID: 35504745
DOI: 10.1016/j.amjcard.2022.04.001

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Glucose
Heart Failure* / complications
Heart Failure* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
Glucose